Home Impact About Us News & Media Our Science Contact Us

News & Media Hub

Catch Up on the Latest News and Media Releases from Syndicate Bio

announcements

Syndicate Bio Partners with National Institute of Cancer Research and Treatment (NICRAT) to Tackle Cancer Disparities in Nigeria with Cancer Genome Project

October 24, 2023

Syndicate Bio has entered into a Memorandum of Understanding with the National Institute of Cancer Research and Treatment (NICRAT), Nigeria's premier institution for cancer research, treatment, and control. Their collaborative initiative focuses on studying the most common cancers in Nigeria, providing valuable insights into their genomic profiles to enhance diagnosis, treatment, and support clinical and pre-clinical research.

Syndicate Bio Partners with Nigerian Institute of Medical Research for Innovative Genomic Drug Discovery in Nigeria

October 18, 2023

Syndicate Bio has signed a significant Memorandum of Understanding with Nigeria's leading research institution, the Nigerian Institute of Medical Research, paving the way for transformative genomic studies in infectious and non-infectious diseases and drug discovery in Nigeria.

Syndicate Bio Presented at the Women of Color in Pharma Summit

September 11, 2023

At the recently concluded Women of Color in Pharma Inaugural Global Summit, our CEO, Dr. Abasi Ene-Obong, delivered a presentation titled ‘The Value Proposition for Doing Business on the Continent.'

Syndicate Bio Participated at the 2023 World Health Summit

September 11, 2023

At the 2023 World Health Summit, our Co-founder and Chief Scientific Officer, Dr Jumi Popoola, delivered a presentation on the ‘Use of predictive genomics to drive healthcare in resource-limited settings.’

Syndicate Bio Presented at the 2023 AAADV Workshop

September 11, 2023

At the 2023 AAADV Workshop, our CEO, Dr Abasi Ene-Obong spoke on 'Genomic Testing in Low-and Middle-Income Countries.'

media Highlights

A Visual Showcase of Our Impact

Dr Abasi Ene-Obong, CEO, Syndicate Bio (2nd L), Prof Usman Malami Aliyu, DG, NICRAT (3rd L), Sen Atiku Abubakar Bagudu, CON, Honourable Minister of Budget and Economic Planning (5th L), Dr. Zainab Bagudu, CEO, MEDICAID (6th L) and other dignitaries after the memorandum of understanding to launch the Syndicate Bio and NICRAT Cancer Genome Nigeria project was signed on 23rd October, 2023, in Abuja

(L-R) Estelle Dogbo, Co-founder & COO Syndicate Bio, Dr Abasi Ene-Obong, Founder & CEO Syndicate Bio, Aminu Yakuku, Ethics Consultant, and Faridah Giwa-Bello, Communications Manager Syndicate Bio after the MoU signing at the 2023 International Cancer Week

Dr. Abasi Ene-Obong, Founder & CEO Syndicate Bio, speaking on the importance of the partnership with NICRAT to tackle cancer care disparities in Nigeria at the opening of the 2023 International Cancer Week

(L-R) Professor Usman Malami Aliyu- Director General NICRAT, Honorable Senator Bagudu, Minister of Budget and Economic Planning, and Dr Abasi Ene-Obong, Founder & CEO Syndicate Bio signing the MoU at the opening of the 2023 International Cancer Week

(Left to right) The Director of Research and Head of Department of Microbiology of NIMR, Prof. Rosemary Audu, Director General of NIMR, Prof. Babatunde Salako, CEO of Syndicate Bio, Dr. Abasi Ene-Obong, and COO of Syndicate Bio, Estelle Dogbo at the Memorandum of Understanding signing

Representatives of the Nigerian Institute of Medical research and Syndicate Bio at the Memorandum of Understanding signing

Director General of Nigerian Institute of Medical Research (NIMR) and CEO of Syndicate Bio exchanging Memorandum of Understanding

Director General of Nigerian Institute of Medical Research (NIMR) and CEO of Syndicate Bio exchanging Memorandum of Understanding

A webinar presentation featuring our co-founder and Chief Scientific Officer, Dr. Jumi Popoola, as she discusses the transformative potential of genomics in predictive, preventive, and precision medicine.

A presentation on 'Genetic Testing in Low- and Middle-Income Countries' by our CEO, Dr. Abasi Ene-Obong, at the 2023 AAADV Workshop on September 13th.

A presentation on 'Predictive genomics and cancer diagnostics in resource-limited settings' by our Co-founder and Chief Scientific Officer, Dr Jumi Popoola, at the 2023 World Health Summit on October 15th.

Get in touch with us